Development of a Method for Determining the Amino Acid Composition of the Pharmaceutical Substance “Glatiramer Acetate” by NMR Spectroscopy

V. I. Krylov; A. A. Kutin; V. A. Yashkir; V. A. Merkulov; N. E. Kuz’mina; S. V. Moiseev

doi:10.1007/s11094-017-1587-2

Development of a Method for Determining the Amino Acid Composition of the Pharmaceutical Substance “Glatiramer Acetate” by NMR Spectroscopy

Autores: Krylov V.¹, Kutin A.¹, Yashkir V.¹, Merkulov V.¹, Kuz’mina N.¹, Moiseev S.¹
Afiliações:
1. National Center for Expert Assessment of Medicines, “Russian Ministry of Health”
Edição: Volume 51, Nº 3 (2017)
Páginas: 226-229
Seção: Article
URL: https://journals.rcsi.science/0091-150X/article/view/244543
DOI: https://doi.org/10.1007/s11094-017-1587-2
ID: 244543

Citar

Texto integral

Acesso aberto
Acesso é fechado

Acesso está concedido
Acesso é fechado

Somente assinantes

Resumo
Sobre autores
Bibliografia
Estatísticas

Resumo

The acid hydrolysis procedure for glatiramer acetate was modified and the characteristic signals in the ¹H and ¹³C spectra were identified, allowing its amino acid composition to be determined. The relative molar contents of amino acids in glatiramer acetate measured by HPLC-MS and by ¹³C and ¹H NMR had close values. ¹³C NMR was found to be a more precise method for assaying the amino acid composition of glatiramer acetate than ¹H NMR.